Crohn's Disease Clinical Trials in Lancaster, California

4 studies are recruiting for crohn's disease in Lancaster, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) in the digestive tract. CD can affect any part of the digestive tract causing many different symptoms including belly pain, diarrhea, tiredne…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Gastro Care Institute /ID# 281071, Lancaster, California
    Locations
    36 in total
    Run by
    AbbVie

    See if you can join NCT07697456 on ClinicalTrials.gov

  2. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinica…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    Om Research LLC ( Site 5038), Lancaster, California
    Locations
    499 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06430801 on ClinicalTrials.gov

  3. A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

    This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Gastro Care Institute, Lancaster, California
    Locations
    225 in total
    Run by
    Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

    See if you can join NCT06226883 on ClinicalTrials.gov

  4. A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

    This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total study duration is up…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Investigational Site Number: 8400001, Lancaster, California
    Locations
    66 in total
    Run by
    Sanofi

    See if you can join NCT06958536 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.